+1 (941) 951-0126
    • Skip to content
    • About Us
      • Leadership Team
      • Scientific Advisors
      • Board of Directors
    • Microbiome Biotherapeutics
      • Human Microbiome
      • MiNE™ Platform
    • Intellectual Property
    • Qi601: The World’s First Microplastic DETOX
    • Plastic and Humans
      • What Are Micro- and Nanoplastics?
      • How Plastics Enter the Human Body
      • The Human Microbiome and Barrier Function
      • Miracle to Menace: How Plastics Rewrote Human History
    • Research
      • DARPA Research
      • Qi601 Biofilm Shield™
    • FAQs
    • News
      • In the News
      • Press Releases
    • Contact
    In the News

    Quorum Innovations is included in Silicon Valley Bank’s report on Microbiome Investment Trends.

    August 22, 2017 Quorum Innovations

    Quorum Innovations is included in SVB Analytics – Emerging Healthcare: / 2017

    Microbiome Investment Trends

     

    Download a PDF of Full Report

    Share:

    Post navigation

    Previous PostU.S. Patent Allowance For Methods Of Identifying A Biologically-Active Composition From A BiofilmNext PostQuorum Innovations Demonstrates Human Microbiome Modulation

    Categories

    • In the News
    • Press Releases

    Recent Posts

    • Miracle to Menace: How Plastics Rewrote Human History
    • Poster Presentation at the 29th Annual TechConnect World Innovation Conference and Expo
    • As Seen in the News
    • A Microscopic Discovery With Massive Implications: Two Physicians Uncover a New Biological Defense Against Microplastics
    • DR. NICHOLAS MONSUL – CHAIRMAN/FOUNDER OF QUORUM INNOVATIONS KEY SPEAKER AT THE MICROBIOME SUMMIT IN VIENNA, AUSTRIA

    Archives

    • January 2026
    • September 2017
    • August 2017
    • October 2016

    powered by the human microbiome

    Quorum Innovations

    2068 Hawthorne Street
    Sarasota, FL 34239
    Mon - Fri | 8:30-5:00
    +1 (941) 951-0126

    About Us

    Quorum Innovations is a pioneering biotherapeutics company dedicated to discovering, developing, and delivering innovative microbiome-derived biotherapeutics to physicians and patients.

    With a deep understanding of the human microbiome’s critical role in health and disease—particularly in barrier defense and immune modulation—Quorum is at the forefront of the rapidly evolving field of microbiome biotherapeutics, harnessing nature’s own microbial allies to restore balance and protect against modern health challenges.

    Navigation

    • Home
    • About Us
    • Microbiome Biotherapeutics
    • Intellectual Property
    • Qi601: The World’s First Microplastic Detox
    • Scientific Research and Discovery
    • News
    • Careers
    • Contact

    • © 2026 Quorum Innovations, All Rights Reserved.